Celebrating Dr. David Segal: A Leader in Science and a Champion for Angelman Syndrome Research
FAST congratulates longtime research partner Dr. David J. Segal on his appointment as Chair of Biochemistry and Molecular Medicine at UC Davis, a milestone for the AS research community.
Investing in the Future of Angelman Syndrome Research: FAST Partners with ASGCT to Support Early-Career Scientists
FAST partners with ASGCT to fund up to three $100,000 Career Development Awards, recruiting early-career scientists to advance neuron-targeted gene and cell therapies for Angelman syndrome.”
Expanding the Pre-Clinical Research Landscape for Angelman Syndrome
FAST currently manages over 20 active research grants for Angelman syndrome and is expanding its infrastructure by broadening its Scientific Advisory Board and streamlining its grants management system.